Cryo-Cell International Inc (CCEL)
XASE:CCEL
Want to see CCEL full AI Analyst Report?
Total Valuation
Cryo-Cell International has a market cap or net worth of $28.35M. The enterprise value is $30.50M.
Market Cap$28.35M
Enterprise Value$30.50M
Share Statistics
Cryo-Cell International has 8,055,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,055,150
Owned by Insiders35.70%
Owned by Institutions7.14%
Financial Efficiency
Cryo-Cell International’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 1.08%.
Return on Equity (ROE)0.13
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)1.08%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee384.96K
Profits Per Employee-29.63K
Employee Count82
Asset Turnover0.51
Inventory Turnover18.04
Valuation Ratios
The current PE Ratio of Cryo-Cell International is 145.3. Cryo-Cell International’s PEG ratio is 0.02.
PE Ratio145.3
PS Ratio1.02
PB Ratio-1.73
Price to Fair Value-1.73
Price to FCF6.12
Price to Operating Cash Flow5.48
PEG Ratio0.02
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.57M and earned -2.43M in profits. Earnings per share was -0.30.
Revenue31.57M
Gross Profit24.19M
Operating Income482.39K
Pretax Income-2.34M
Net Income-2.43M
EBITDA480.58K
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was 5.18M and capital expenditures -235.49K, giving a free cash flow of 4.94M billion.
Operating Cash Flow5.18M
Free Cash Flow4.94M
Free Cash Flow per Share0.61
Dividends & Yields
Cryo-Cell International pays an annual dividend of $0.15, resulting in a dividend yield of 11.14%
Dividend Per Share$0.15
Dividend Yield11.14%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change-30.31%
50-Day Moving Average3.34
200-Day Moving Average4.05
Relative Strength Index (RSI)49.87
Average Volume (3m)4.07K
Important Dates
Cryo-Cell International upcoming earnings date is Jul 10, 2026, TBA (Confirmed).
Last Earnings DateApr 14, 2026
Next Earnings DateJul 10, 2026
Ex-Dividend Date―
Financial Position
Cryo-Cell International as a current ratio of 0.59, with Debt / Equity ratio of -13.02%
Current Ratio0.59
Quick Ratio0.57
Debt to Market Cap0.10
Net Debt to EBITDA6.00
Interest Coverage Ratio0.23
Taxes
In the past 12 months, Cryo-Cell International has paid 92.23K in taxes.
Income Tax92.23K
Effective Tax Rate-0.04
Enterprise Valuation
Cryo-Cell International EV to EBITDA ratio is 72.83, with an EV/FCF ratio of 6.67.
EV to Sales1.11
EV to EBITDA72.83
EV to Free Cash Flow6.67
EV to Operating Cash Flow6.39
Balance Sheet
Cryo-Cell International has $2.90M in cash and marketable securities with $2.40M in debt, giving a net cash position of $504.86K billion.
Cash & Marketable Securities$2.90M
Total Debt$2.40M
Net Cash$504.86K
Net Cash Per Share$0.06
Tangible Book Value Per Share-$2.65
Margins
Gross margin is 77.47%, with operating margin of 1.53%, and net profit margin of -7.70%.
Gross Margin77.47%
Operating Margin1.53%
Pretax Margin-7.40%
Net Profit Margin-7.70%
EBITDA Margin1.52%
EBIT Margin-0.86%
Analyst Forecast
The average price target for Cryo-Cell International is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-2.56%
EPS Growth Forecast-2181.76%